Groupe de RFA RADIO

Although no cure exists, ongoing research explores gene-based therapies, metabolic modulation, and enzyme replacement strategies. These approaches aim to address the underlying causes of ZSD.

Improved understanding of peroxisomal biology is opening new avenues for intervention. While still experimental, these efforts represent hope for future care improvements.

Research momentum continues to influence long-term prospects within the Zellweger Spectrum Disorder Market.